Nuclear medicine and PET imaging course

Course dates

Registration for the 2026 course is now closed. Please check back for March 2027 course dates.

Venue

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Oakleaf Avenue, Sutton, Surrey, UK.

Course overview

This course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

This longstanding course is designed to teach the scientific principles upon which nuclear medicine imaging is based. It gives an introduction to the underlying physics and radiochemistry principles which form the basis of nuclear medicine before delivering a set of detailed lectures covering all aspects of imaging.

The course is run over four days (Tuesday to Friday). Each day is designed to cover a particular theme. The first day primarily covers radionuclides and radiation protection; the second day focuses on gamma camera and SPECT imaging; the third day is dedicated to PET/CT imaging. The fourth day concentrates on individual patient dosimetry/treatment planning for molecular radiotherapy.

The course is intended to be useful for medical physicists in training and postgraduate students, as well as more experienced professionals seeking to refresh or expand their knowledge in key areas.

The course assumes some familiarity with general principles of physics, but no specific knowledge of nuclear medicine imaging is assumed. A provisional lecture list is available below.

This is a CPD course approved by IPEM.

This course is currently undergoing its annual accreditation review by the European Board for Accreditation in Medical Physics (EBAMP). Accreditation is pending and will be confirmed once the evaluation process is complete.

Provisional lecture list

Day 1: Radionuclides & radiation protection

  • Physics for Nuclear Medicine
  • Radionuclide Production
  • Radiopharmaceuticals
  • Nuclear Medicine / PET Case Studies
  • Radiation Detectors
  • Radiation Protection in Nuclear Medicine

Day 2: Gamma camera imaging

  • The Gamma Camera
  • Nuclear Medicine Imaging Techniques
  • SPECT Imaging
  • Iterative Reconstruction
  • Nuclear Medicine / PET Case Studies
  • Quality Control and Performance Assessment of Gamma Camera Systems
  • Image Processing Techniques
  • Advances in Gamma Camera Technology

Day 3: PET/CT

  • Principles of CT imaging
  • PET Instrumentation
  • PET Tracer Production and Molecular Targeting
  • Principles of Tracer Kinetics
  • The Future of Nuclear Medicine
  • PET in Radiotherapy
  • Advances in PET Technology

Day 4: Internal dosimetry

  • Introduction to the MIRD Schema
  • Quantitative Imaging
  • Absorbed Dose Calculation Algorithms
  • Applications of Internal Dosimetry
  • Radiobiology for MRT
  • Dosimetry in Emerging Clinical Therapies
  • Practical Session

Each lecture will be 45 minutes in duration.

Registration & Course fees

Online Registration Form

Downloadable Registration Form (PDF)

All current course registration fees are given on our registration form. Delegates wishing to attend on particular days only, will be charged on a pro rata basis. 

The cost includes lunches and light refreshments. Lecture notes and a certificate of attendance are provided.

You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or completed bank transfer/online payment. We are unable to accept provisional bookings.

The number of participants is limited, so early booking is advised.  Applications from outside the UK are welcome.

Closing date for completed registrations: TBC

 

Related documents

Provisional Timetable

Provisional Lecture Synopses

Sutton Site Map

Contacts

Course organiser: Dr Iain Murray (Royal Marsden Hospital)

Tel: +44 (0)20 8661 3717

For registration details and any other queries contact:

Course administrator: Mrs Jessica Keegan

Tel: +44 (0)20 8661 3075

IPEM approved logo

Latest ICR News

Image of immunofluorescence staining of bladder tumour tissue. Some areas appear lighter green, some dark blue, and others black.
Immunotherapy boost can spare more bladder cancer patients major surgery

02/06/26

An immunotherapy helps bladder cancer patients remain cancer free and enables them to avoid surgery, a phase II trial has found.
See full story
Histopathologic image illustrating squamous cell carcinoma.
Immunotherapy injection shrinks tumours in patients with recurrent and/or metastatic head and neck cancer

31/05/26

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has stopped responding to standard treatments, according to research led by scientists at The Institute of Cancer Research, London
See full story
Image of pill bottle with pills spilling out
New targeted therapy shrinks advanced gastrointestinal tumours for 61 per cent of patients in an early study

30/05/26

A new, targeted cancer therapy for advanced gastrointestinal stromal tumours (GIST) has shown promising early results, with 61 per cent of patients who received velzatinib as first-line treatment experiencing tumour shrinkage of 30 per cent or over. The results could pave the way for a larger trial to evaluate this therapy as a first-line alternative to imatinib, which has been the standard treatment for more than two decades.
See full story
Big Bang moment in bowel cancer research
Targeted therapy shows promise for patients with advanced colorectal cancer in a first-in-human study

30/05/26

A targeted antibody therapy combined with standard chemotherapy has shown early signs of tumour shrinkage and disease control in patients with advanced bowel cancer, according to new Phase I clinical trial results from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust.
See full story